An International Randomized Phase Iii Trial of Pulse Actinomycin-D Versus Multi-Day Methotrexate for the Treatment of Low Risk Gestational Trophoblastic Neoplasia; Nrg/Gog 275
AuthID
P-00V-T7S
P-00V-T7S